Search

Your search keyword '"Lee, Hye‐Soon"' showing total 15 results
Start Over Author "Lee, Hye‐Soon" Journal journal of rheumatic diseases
15 results on '"Lee, Hye‐Soon"'

2. Clinical and Genetic Risk Factors Associated With the Presence of Lupus Nephritis

Author

Shin, Jung-Min, primary, Kim, Dam, additional, Kwon, Young-Chang, additional, Ahn, Ga-Young, additional, Lee, Jiyoung, additional, Park, Youngho, additional, Lee, Yeon-Kyung, additional, Lee, Tae-Han, additional, Park, Dae Jin, additional, Song, Yeo-Jin, additional, Ha, Eunji, additional, Kim, Kwangwoo, additional, Bang, So-Young, additional, Choi, Chan-Bum, additional, Lee, Hye-Soon, additional, and Bae, Sang-Cheol, additional

Published
2021
Full Text
View/download PDF

5. Prevalence and Associated Factors for Non-adherence in Patients with Rheumatoid Arthritis

Author

Kim, Dam, primary, Choi, Ji-Young, additional, Cho, Soo-Kyung, additional, Choi, Chan-Bum, additional, Bang, So-Young, additional, Cha, Hoon-Suk, additional, Choe, Jung-Yoon, additional, Chung, Won Tae, additional, Hong, Seung-Jae, additional, Kim, Tae-Hwan, additional, Kim, Tae-Jong, additional, Koh, Eunmi, additional, Lee, Hye-Soon, additional, Lee, Jisoo, additional, Lee, Shin-Seok, additional, Lee, Sung Won, additional, Park, Sung-Hoon, additional, Shim, Seung-Cheol, additional, Yoo, Dae-Hyun, additional, Yoon, Bo Young, additional, Bae, Sang-Cheol, additional, and Sung, Yoon-Kyoung, additional

Published
2018
Full Text
View/download PDF

6. Productivity Loss of Rheumatoid Arthritis Patients according to the Their Stages of the Disease Activity Score

Author

Bae, Sang-Cheol, primary, Cha, Jin-Hye, additional, Choe, Jung-Yoon, additional, Choi, Sung Jae, additional, Cho, Soo-Kyung, additional, Chung, Won-Tae, additional, Joung, Chung-Il, additional, Jung, Young-Ok, additional, Kang, Young Mo, additional, Kim, Dong-Wook, additional, Kim, Jinseok, additional, Kim, Young-Joo, additional, Lee, Choong-Ki, additional, Lee, Hye-Soon, additional, Lee, Jisoo, additional, Lee, Sang-Heon, additional, Lee, Sang-Hoon, additional, Lee, Shin-Seok, additional, Lee, Yeon-Ah, additional, Nah, Seong-Su, additional, Shim, Seung Cheol, additional, Song, Gwan-Gyu, additional, Suh, Chang-Hee, additional, Won, Soyoung, additional, Yoo, Wan-Hee, additional, and Yoon, Bo Young, additional

Published
2018
Full Text
View/download PDF

9. Diffuse Skeletal Hemangiomatosis Mimicking Sacroiliitis

Author

Hwang, Soon Woo, primary, Lee, Jung Hoon, additional, Ryu, Jeong Ah, additional, Choi, Jong Min, additional, Lee, Sang Ki, additional, Kim, Hyun Sung, additional, Kim, Tai-Seung, additional, Kim, Tae-Hwan, additional, Lee, Hye-Soon, additional, and Bang, So-Young, additional

Published
2014
Full Text
View/download PDF

10. Prediction for TNF Inhibitor Users in RA Patients According to Reimbursement Criteria Based on DAS28

Author

Won, Soyoung, primary, Sung, Yoon-Kyoung, additional, Cho, Soo-Kyung, additional, Choi, Chan-Bum, additional, Koh, Eun-Mi, additional, Kim, Seong-Kyu, additional, Kim, Jinseok, additional, Kim, Tae-Hwan, additional, Kim, Hyoun Ah, additional, Nah, Seong-Su, additional, Bang, So-Young, additional, Suh, Chang-Hee, additional, Shim, Seung Cheol, additional, Yoo, Dae-Hyun, additional, Yoon, Bo Young, additional, Lee, Sang-Hoon, additional, Lee, Sung Won, additional, Lee, Shin-Seok, additional, Lee, Yeon-Ah, additional, Lee, Jaejoon, additional, Lee, Jisoo, additional, Lee, Hye-Soon, additional, Lim, Mi Kyoung, additional, Jun, Jae-Bum, additional, Jeon, Chan Hong, additional, Jung, Young Ok, additional, Chung, Won Tae, additional, Cha, Hoon-Suk, additional, Choe, Jung-Yoon, additional, Hong, Seung-Jae, additional, and Bae, Sang-Cheol, additional

Published
2014
Full Text
View/download PDF

15. Real-world effectiveness of a single conventional disease-modifying anti-rheumatic drug (cDMARD) plus an anti-TNF agent versus multiple cDMARDs in rheumatoid arthritis: a prospective observational study.

Author

So MW, Kim SH, Kim DW, Sung YK, Choe JY, Lee SI, Hur JW, Lee HS, Lee SH, Kim JR, and PharmD

Abstract

Objective: The objective of this prospective, observational multicenter study (NCT03264703) was to compare the effectiveness of single conventional disease-modifying anti-rheumatic drug (cDMARD) plus anti-tumor necrosis factor (TNF) therapy versus multiple cDMARD treatments in patients with moderate-to-severe rheumatoid arthritis (RA) following cDMARD failure in the real-world setting in South Korea., Methods: At the treating physicians' discretion, patients received single cDMARD plus anti-TNF therapy or multiple cDMARDs. Changes from baseline in disease activity score 28-joint count with erythrocyte sedimentation rate (DAS28-ESR), corticosteroid use, and Korean Health Assessment Questionnaire (KHAQ-20) scores were evaluated at 3, 6, and 12 months., Results: Of 207 enrollees, the final analysis included 45 of 73 cDMARD plus anti-TNF and 91 of 134 multiple-cDMARD recipients. There were no significant between-group differences (BGDs) in ANCOVA-adjusted changes from baseline in DAS28-ESR at 3, 6 (primary endpoint), and 12 months (BGDs -0.18, -0.38, and -0.03, respectively). More cDMARD plus anti-TNF than multiple-cDMARD recipients achieved a >50% reduction from baseline in corticosteroid dosage at 12 months (35.7% vs 14.6%; p=0.007). Changes from baseline in KHAQ-20 scores at 3, 6, and 12 months were significantly better with cDMARD plus anti-TNF therapy than with multiple cDMARDs (BGD -0.18, -0.19, and -0.19 points, respectively; all p ≤ 0.024)., Conclusion: In the real-world setting, relative to multiple cDMARDs, single cDMARD plus anti-TNF therapy significantly improved quality-of-life scores and reduced corticosteroid use, with no significant BGD in disease activity, in RA patients in whom previous cDMARD therapy had failed., Competing Interests: CONFLICT OF INTEREST Y.K.S. has received research funding from Bristol Myers Squibb, Eisai Korea Inc., Pfizer Pharmaceuticals, Yuhan Pharmaceuticals, and JW Pharmaceuticals Corporation; and consulting fees from Immunoforge Co. Ltd. M.W.S., S.H.K., D.W.K., J.Y.C., S.I.L., J.W.H., H.S.L., and S.H.L. have received research funding from Eisai Korea Inc. for this study. J.R.K. is an employee of Eisai Korea Inc., (Copyright © 2024 by The Korean College of Rheumatology. All rights reserved.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results